PNC Financial Services Group’s Entera Bio ENTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1K Hold
10,000
﹤0.01% 3910
2025
Q4
$19.4K Hold
10,000
﹤0.01% 3675
2025
Q3
$19.2K Hold
10,000
﹤0.01% 3664
2025
Q2
$19K Hold
10,000
﹤0.01% 3596
2025
Q1
$17K Hold
10,000
﹤0.01% 3618
2024
Q4
$21.2K Sell
10,000
-3,000
-23% -$5.6K ﹤0.01% 3506
2024
Q3
$24.7K Hold
13,000
﹤0.01% 3408
2024
Q2
$23.9K Hold
13,000
﹤0.01% 3390
2024
Q1
$21.7K Hold
13,000
﹤0.01% 3412
2023
Q4
$7.8K Hold
13,000
﹤0.01% 3818
2023
Q3
$9.43K Buy
13,000
+3,000
+30% +$2.21K ﹤0.01% 3778
2023
Q2
$8.43K Hold
10,000
﹤0.01% 3950
2023
Q1
$11.6K Hold
10,000
﹤0.01% 3749
2022
Q4
$7.3K Hold
10,000
﹤0.01% 3878
2022
Q3
$10K Hold
10,000
﹤0.01% 3764
2022
Q2
$13K Hold
10,000
﹤0.01% 3682
2022
Q1
$29K Buy
+10,000
New +$24K ﹤0.01% 3392

Other funds holding ENTX

PNC Financial Services Group's ENTX Position: Q1 2026 in Review

PNC Financial Services Group held its Entera Bio (ENTX) position steady in Q1 2026 at 10,000 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3910.

PNC Financial Services Group first reported a position in ENTX in Q1 2022 and has held it in 17 quarters since. The position peaked at $29K in Q1 2022. 26 funds tracked by Wall St. Rank hold ENTX as of Q1 2026.

  • PNC Financial Services Group held 10,000 shares of Entera Bio worth $11.1K as of Q1 2026.
  • PNC Financial Services Group left its Entera Bio share count unchanged in Q1 2026.
  • Entera Bio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3910 holding.
  • PNC Financial Services Group first reported a position in Entera Bio in Q1 2022 and has held it in 17 quarters since.
  • PNC Financial Services Group's Entera Bio position peaked at $29K in Q1 2022.
  • 26 funds tracked by Wall St. Rank held Entera Bio as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.